Metabolically healthy obesity and the risk of cardiovascular disease in the elderly population

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Dhana, Klodian ^a   Koolhaas, Chantal M ^a   Van Rossum, Elisabeth F C ^a   Ikram, M Arfan ^a   Hofman, Albert ^a,b   Kavousi, Maryam ^a   Franco, Oscar H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLICALLY BENIGN OBESITY; MORTALITY; MULTIVARIATE ANALYSIS; NETHERLANDS; OBESITY; PROPORTIONAL HAZARDS MODEL; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; MIDDLE AGED; OBESITY, METABOLICALLY BENIGN; PROSPECTIVE STUDY; RISK FACTOR;

AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; OBESITY, METABOLICALLY BENIGN; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84964682968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154273     Document Type: Article

References (35)

1. Chapman IM. Obesity paradox during aging. Interdiscip Top Gerontol. 2010; 37(1):20-36.
2. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. Jama. 2013; 309(1):71-82. PMID: 23280227. doi: 10.1001/jama.2012.113905
3. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the us population (nhanes 1999-2004). Arch Intern Med. 2008; 168(15):1617-24. doi: 10.1001/archinte.168.15.1617 PMID: 18695075
4. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004; 109(6):706-13. PMID: 14970104.
5. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91 (8):2906-12. PMID: 16735483.
6. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013; 36(8):2388-94. PMID: 23491523. doi: 10.2337/dc12-1971
7. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol. 2007; 100(11):1654-8. PMID: 18036364.
8. Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J. 2014. Epub 2014/03/29. ehu123 [pii] doi: 10.1093/eurheartj/ehu123 PMID: 24670711.
9. Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med. 2014; 174(1):15-22. PMID: 24217719. doi: 10.1001/jamainternmed.2013.10522
10. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010; 121(2):230-6. PMID: 20038741. doi: 10.1161/CIRCULATIONAHA.109.887521
11. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009; 32(12):2297-9. PMID: 19729521. doi: 10.2337/dc09-0574
12. Chapman I. Obesity in old age. 2008.
13. Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr. 2005; 82(5):923-34. ISI:000233153000003. PMID: 16280421
14. Hofman A, Brusselle GG, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015; 30(8):661-708. PMID: 26386597. doi: 10.1007/s10654-015-0082-x
15. Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D. The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol. 1991; 133(11):1078-92. Epub 1991/06/01. PMID: 2035512.
16. Koller MT, Leening MJ, Wolbers M, Steyerberg EW, Hunink MG, Schoop R, et al. Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study. Ann Intern Med. 2012; 157(6):389-97. Epub 2012/09/19. 1359218 [pii] doi: 10.7326/0003-4819-157-6-201209180-00002 PMID: 22986376; PubMed Central PMCID: PMC3644640.
17. Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012; 156(6):438-44. PMID: 22431676. doi: 10.7326/0003-4819-156-6-201203200-00006
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009; 150(9):604-12. PMID: 19414839
19. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16):1640-5. PMID: 19805654. doi: 10.1161/CIRCULATIONAHA.109. 192644
20. Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr., Gibbons R, et al. 2013 ACC/ AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(25 Pt B):2935-59. Epub 2013/11/19. S0735-1097(13)06031-2 [pii] doi: 10.1016/j.jacc.2013.11.005 PMID: 24239921.
21. Leening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol. 2012; 27(3):173-85. PMID: 22388767. doi: 10.1007/s10654-012-9668-8
22. Bos MJ, Koudstaal PJ, Hofman A, Ikram MA. Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study. PLoS Med. 2014; 11(4):e1001634. Epub 2014/05/02. doi: 10.1371/journal.pmed.1001634 PMEDICINE-D-13-03607 [pii]. PMID: 24781247; PubMed Central PMCID: PMC4004543.
23. Lin DY, Fleming TR, De Gruttola V. Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med. 1997; 16(13):1515-27. PMID: 9249922.
24. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American statistical association. 1999; 94(446):496-509.
25. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998; 338(1):1-7. Epub 1998/01/01. doi: 10. 1056/NEJM199801013380101 PMID: 9414324.
26. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995; 141(12):1117-27. Epub 1995/06/15. PMID: 7771450.
27. Dhana K, Ikram MA, Hofman A, Franco OH, Kavousi M. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2015; 101(5):377-83. Epub 2014/12/17. heartjnl-2014-306704 [pii] doi: 10.1136/heartjnl-2014-306704 PMID: 25502814.
28. Myint PK, Welch AA. Healthier ageing. Bmj. 2012; 344:e1214. PMID: 22411918. doi: 10.1136/bmj. e1214
29. Roche AF, Sievogel RM, Chumlea WC, Webb P. Grading body fatness from limited anthropometric data. Am J Clin Nutr. 1981; 34(12):2831-8. PMID: 7315784.
30. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007; 7:220. PMID: 17727697.
31. Wildman RP. Healthy obesity. Curr Opin Clin Nutr Metab Care. 2009; 12(4):438-43. PMID: 19474713. doi: 10.1097/MCO.0b013e32832c6db7
32. Janssen I, Katzmarzyk PT, Ross R. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol. 2004; 14(8):585-91. PMID: 15350959.
33. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005; 90(7):4145-50. PMID: 15855252.
34. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001; 86(3):1020-5. PMID: 11238480.
35. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J. 2013; 34 (5):389-97. PMID: 22947612. doi: 10.1093/eurheartj/ehs174